A Case of Primary Pulmonary Hypertension in Pregnancy Presented as Massive Hemoptysis
![]() ![]() |
Kim, Myung Sook
(Department of Internal Medicine, Daejon St. Mary's Hospital, The Catholic University of Korea)
Kim, Hyoung Doo (Department of Internal Medicine, Daejon St. Mary's Hospital, The Catholic University of Korea) Kim, Seok Chan (Department of Internal Medicine, Daejon St. Mary's Hospital, The Catholic University of Korea) Kwan, Soon Suk (Department of Internal Medicine, Daejon St. Mary's Hospital, The Catholic University of Korea) Kim, Young Kyoon (Department of Internal Medicine, Daejon St. Mary's Hospital, The Catholic University of Korea) Kim, Kwan Hyoung (Department of Internal Medicine, Daejon St. Mary's Hospital, The Catholic University of Korea) Moon, Hwa Sik (Department of Internal Medicine, Daejon St. Mary's Hospital, The Catholic University of Korea) Song, Jeong Sup (Department of Internal Medicine, Daejon St. Mary's Hospital, The Catholic University of Korea) Park, Sung Hak (Department of Internal Medicine, Daejon St. Mary's Hospital, The Catholic University of Korea) |
1 | Goodwin TM, Gherman RB, Hameed A, Elkayam U. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. Am J ObstetGynecol 1999;180:64-7 |
2 | Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. AnnIntern Med 1996;124:820-4 |
3 | Mccaffrey RM, Dunn LJ. Primary pulmonary hypertension in pregnancy. Obstet Gynecol Surv 1964;19:567-91 |
4 | Robinson JN, Banerjee R, Landzberg MJ, Thiet MP. Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension. Am J Obstet Gynecol1999;180:1045-6 |
5 | Monnery L, Nanson J, Charlton G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth 2001;87:295-8 |
6 | Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998;101(5):927-34 |
7 | Lam GK, Stafford RE, Thorp J, Moise KJ Jr, Cairns BA. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol 2001;98:895-8 |
8 | Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am CollCardiol 1998;31:1650-7 |
9 | Mikhail G, Gibbs J, Richardson M, Wright G, Khaghani A, Banner N, Yacoub M. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension. Eur Heart J 1997;18: 1499-504 |
10 | Voelkel NF, Tuder RM. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 1995;8(12):2129-38 |
11 | Easterling TR, Ralph DD, Schmucker BC. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol 1999;93:494-8 |
12 | Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327:70-5 |
13 | Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, et al. A comparison of continuous intravenous epoprostenol(prostacyclin) with conventional therapy for primary pulmonary hypertension: The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996;334:296-302 |
![]() |